Midgard Science

Labs / CDMO: development & manufacturing

Novoheart

Hong Kong, China · novoheart.com

GMP

On your own

Free. Their own form.

Contact Novoheart directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

Novoheart develops bioengineered human heart constructs for drug discovery, disease modeling, and screening. It serves researchers and drug developers working on cardiac therapeutics, with laboratory locations in Boston, Hong Kong, and a Singapore facility coming soon.

They take quote requests by email.

What they offer

  • Human embryonic or induced pluripotent stem cell differentiation to ventricular cardiomyoc

    Differentiates pluripotent stem cells into ventricular cardiomyocytes.

  • Mini-Heart engineered tissue assays using specified cell lines

    Provides engineered human heart tissue assays built from specified cell lines.

  • Human Ventricular Cardiac Anisotropic Sheet (hvCAS)

    Offers anisotropic sheet assays for cardiac modeling and testing.

  • Human Ventricular Cardiac Tissue Strip (hvCTS)

    Offers tissue strip assays for contractility and related cardiac functional testing.

  • Human Heart-in-a-Jar™ / Human Ventricular Cardiac Organoid Chamber (hvCOC)

    Provides a human heart-in-a-jar organoid chamber model for testing toxicity and efficacy.

  • Drug discovery

    Supports drug discovery using human-specific cardiac models.

  • Cardiotoxicity screening

    Screens compounds for cardiac toxicity.

  • Disease modeling of rare/genetic and acquired heart diseases

    Builds disease models for rare, genetic, and acquired heart diseases.

  • Efficacy studies

    Assesses therapeutic efficacy in cardiac models.

  • Dose titration and optimization

    Evaluates dose response and optimization for treatments.

  • Patient cohort-specific responses to drug treatments

    Tests responses to treatments in specified patient cohorts.

  • Screening and phenotyping services

    Provides screening and phenotyping for cardiac models and compounds.

  • Research and development / consultation related to new disease models and therapeutics

    Provides R&D and consultation for new disease models and therapeutics.

What they work on

Modalities
gene and cell products
Species and models
human pluripotent stem cells, human embryonic stem cells, human induced pluripotent stem cells, human ventricular cardiomyocytes, heart failure with preserved ejection fraction, COVID, arrhythmias, Long QT Syndrome, Friedreich's Ataxia
Assays and studies
electrophysiology, arrhythmia, contractility, pressure-volume, toxicity, efficacy, screening, phenotyping, dose response, cardiotoxicity
Instruments and platforms
CTScreen System Software, mini-Heart T-Monitor, mini-Heart T-Processor, mini-Heart T-Analyzer
Therapeutic areas
heart disease, cardiac therapeutics, drug discovery
Sites
Boston, USA · Hong Kong, Hong Kong · Singapore, Singapore
Serves
global
Address
6 Tide Street, 2nd Floor, Boston, MA 02210, USA
Founded
2014

Public records

Ownership
Novoheart Holdings Inc. · CA GLEIF

Similar labs. 3C Therapeutics, Alchem Laboratories Corporation, ARSI Canada Inc, Aurigene Pharmaceutical Services

Found in a contract services directory. Listing built from novoheart.com. Work here? Claim this listing.

Novoheart · Midgard Science